Cover Story

Over the last decade, several studies in humans have found that high-intensity interval training (HIIT), an exercise training program involving brief bouts of intense exercise (90-100% of VO2 max) followed by periods of recovery, can elicit similar metabolic adaptations to classical endurance exercise training but with a much shorter time commitment. Importantly, recent studies have established that HIIT can lower blood glucose and markers of insulin resistance independently of alterations in adiposity/body mass in individuals with insulin resistance and type 2 diabetes.

Marcinko and colleagues show that HIIT leads to a substantial improvement in exercise capacity without altering body mass or adiposity and that this is accompanied by significant reductions in fasting and fed blood glucose levels. HIIT improves adipose tissue insulin sensitivity independently of adipocyte cell size, macrophage accumulation in adipose tissue, adipose tissue inflammation or markers of adipose tissue browning. It also improves liver insulin sensitivity independently of reductions in liver triacylglycerol/diacylglycerol/ceramide levels. Improvements in adipose and liver insulin sensitivity occur independently of acetyl-CoA carboxylase (ACC) phosphorylation, which the authors have previously shown is required for the insulin sensitizing effects of metformin. These findings indicate that HIIT can uncouple inflammation and lipid metabolism from insulin sensitivity and does not depend on AMP-activated protein kinase (AMPK) phosphorylation and inhibition of ACC.



Full Text
The 60 Second Metabolist
In this section authors briefly report on their work recently published in Molecular Metabolism.

Watch the most recent interview by clicking the video still. The link "referring article" directs you to this author's publication.



Andrea Rozo, Doris Stoffers
Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA
Referring article

Other Scientists...
Issue Alert
If you want to be alerted via email when new content that matches your interests is available, please login or register at www.molmetab.com/user/alerts
Conferences & Events
September
17 − 19
2017
5th Helmholtz-Nature Medicine Diabetes Conference
Munich, Germany
October
1 − 5
2017
Lifetime Influence of Genes and Environment
Copenhagen, Denmark
October
15 − 17
2017
Cell Symposia: Metabolic Disease Therapies
San Diego, USA
Supported by